Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Valent BioSciences LLC has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners across 3 art units, so examiner assignments are fully separated while some art-unit overlap exists.
ATKINSON, JOSHUA ALEXANDER handles 1 pending matter. Counsel can use the art-unit grouping to look for common examination themes, but response preparation must address the distinct examiner records.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ATKINSON, JOSHUA ALEXANDER | 1 | 51.8% | +27.5% |
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 53.1% | +20.6% |
| DIOU BERDECIA, LUIS EUGENIO | 1 | 50.0% | +21.5% |
| VIGIL, TORIANA NICHOLE | 1 | 52.9% | +26.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19080145 | AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF | ATKINSON, JOSHUA ALEXANDER | — |
| 18944146 | (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18663567 | STONE FRUIT QUALITY | DIOU BERDECIA, LUIS EUGENIO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17963270 | MIXTURE OF PYRETHROIDS AND MILBEMYCINS AND USES THEREOF | VIGIL, TORIANA NICHOLE | 17d overdue |
| 19080145 | AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF | ATKINSON, JOSHUA ALEXANDER | — |
| 18944146 | (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18663567 | STONE FRUIT QUALITY | DIOU BERDECIA, LUIS EUGENIO | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 1617 | 1 |
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19080145 | AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF | ATKINSON, JOSHUA ALEXANDER | 1612 | §103§112 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 18944146 | (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103§112 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18663567 | STONE FRUIT QUALITY | DIOU BERDECIA, LUIS EUGENIO | 1792 | §103§112 | Final Rejection | — | Pending | May 14, 2024 |
| 17963270 | MIXTURE OF PYRETHROIDS AND MILBEMYCINS AND USES THEREOF | VIGIL, TORIANA NICHOLE | 1612 | §103 | Non-Final OA | 17d overdue | Pending | Oct 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialValent BioSciences LLC has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Joshua Alexander Atkinson has the most, with 1 of Valent BioSciences LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
